Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.40 | N/A | +9.30% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.40 | N/A | +9.30% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about the current market environment but emphasized their commitment to operational improvements. They did not provide specific guidance for the upcoming quarters.
We are focused on improving our operational efficiency.
Current market conditions present challenges that we are addressing.
Teladoc's earnings report shows a mixed picture, with a narrower-than-expected loss on EPS but no revenue figures available. The stock fell by 2.52%, likely reflecting investor concerns about the company's operational challenges and lack of guidance. The defensive tone from management suggests they are navigating a tough market environment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KONINKLIJKE PHILIPS ADR
Jul 24, 2023